Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Celiac Disease Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 First Line of Treatment
1.2.3 Second Line of Treatment
1.3 Market by Application
1.3.1 Global Celiac Disease Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Celiac Disease Drugs Market Perspective (2018-2033)
2.2 Celiac Disease Drugs Growth Trends by Region
2.2.1 Global Celiac Disease Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Celiac Disease Drugs Historic Market Size by Region (2018-2023)
2.2.3 Celiac Disease Drugs Forecasted Market Size by Region (2024-2033)
2.3 Celiac Disease Drugs Market Dynamics
2.3.1 Celiac Disease Drugs Industry Trends
2.3.2 Celiac Disease Drugs Market Drivers
2.3.3 Celiac Disease Drugs Market Challenges
2.3.4 Celiac Disease Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Celiac Disease Drugs Players by Revenue
3.1.1 Global Top Celiac Disease Drugs Players by Revenue (2018-2023)
3.1.2 Global Celiac Disease Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Celiac Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Celiac Disease Drugs Revenue
3.4 Global Celiac Disease Drugs Market Concentration Ratio
3.4.1 Global Celiac Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Drugs Revenue in 2022
3.5 Celiac Disease Drugs Key Players Head office and Area Served
3.6 Key Players Celiac Disease Drugs Product Solution and Service
3.7 Date of Enter into Celiac Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Drugs Breakdown Data by Type
4.1 Global Celiac Disease Drugs Historic Market Size by Type (2018-2023)
4.2 Global Celiac Disease Drugs Forecasted Market Size by Type (2024-2033)
5 Celiac Disease Drugs Breakdown Data by Application
5.1 Global Celiac Disease Drugs Historic Market Size by Application (2018-2023)
5.2 Global Celiac Disease Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Celiac Disease Drugs Market Size (2018-2033)
6.2 North America Celiac Disease Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Celiac Disease Drugs Market Size by Country (2018-2023)
6.4 North America Celiac Disease Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Celiac Disease Drugs Market Size (2018-2033)
7.2 Europe Celiac Disease Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Celiac Disease Drugs Market Size by Country (2018-2023)
7.4 Europe Celiac Disease Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Celiac Disease Drugs Market Size (2018-2033)
8.2 Asia-Pacific Celiac Disease Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Celiac Disease Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Celiac Disease Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Celiac Disease Drugs Market Size (2018-2033)
9.2 Latin America Celiac Disease Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Celiac Disease Drugs Market Size by Country (2018-2023)
9.4 Latin America Celiac Disease Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Celiac Disease Drugs Market Size (2018-2033)
10.2 Middle East & Africa Celiac Disease Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Celiac Disease Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Celiac Disease Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Celiac Disease Drugs Introduction
11.1.4 Roche Revenue in Celiac Disease Drugs Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Celiac Disease Drugs Introduction
11.2.4 Merck Revenue in Celiac Disease Drugs Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Celiac Disease Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Celiac Disease Drugs Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 BiolineRx
11.4.1 BiolineRx Company Detail
11.4.2 BiolineRx Business Overview
11.4.3 BiolineRx Celiac Disease Drugs Introduction
11.4.4 BiolineRx Revenue in Celiac Disease Drugs Business (2018-2023)
11.4.5 BiolineRx Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Celiac Disease Drugs Introduction
11.5.4 Pfizer Revenue in Celiac Disease Drugs Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Innovate Biopharmaceuticals
11.6.1 Innovate Biopharmaceuticals Company Detail
11.6.2 Innovate Biopharmaceuticals Business Overview
11.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Introduction
11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2018-2023)
11.6.5 Innovate Biopharmaceuticals Recent Development
11.7 ImmusanT
11.7.1 ImmusanT Company Detail
11.7.2 ImmusanT Business Overview
11.7.3 ImmusanT Celiac Disease Drugs Introduction
11.7.4 ImmusanT Revenue in Celiac Disease Drugs Business (2018-2023)
11.7.5 ImmusanT Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Celiac Disease Drugs Introduction
11.8.4 Novartis Revenue in Celiac Disease Drugs Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Celiac Disease Drugs Introduction
11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Drugs Business (2018-2023)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Immunomedics
11.10.1 Immunomedics Company Detail
11.10.2 Immunomedics Business Overview
11.10.3 Immunomedics Celiac Disease Drugs Introduction
11.10.4 Immunomedics Revenue in Celiac Disease Drugs Business (2018-2023)
11.10.5 Immunomedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Celiac Disease Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of First Line of Treatment
Table 3. Key Players of Second Line of Treatment
Table 4. Global Celiac Disease Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Celiac Disease Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Celiac Disease Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Celiac Disease Drugs Market Share by Region (2018-2023)
Table 8. Global Celiac Disease Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Celiac Disease Drugs Market Share by Region (2024-2033)
Table 10. Celiac Disease Drugs Market Trends
Table 11. Celiac Disease Drugs Market Drivers
Table 12. Celiac Disease Drugs Market Challenges
Table 13. Celiac Disease Drugs Market Restraints
Table 14. Global Celiac Disease Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Celiac Disease Drugs Market Share by Players (2018-2023)
Table 16. Global Top Celiac Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2022)
Table 17. Ranking of Global Top Celiac Disease Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Celiac Disease Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Celiac Disease Drugs Product Solution and Service
Table 21. Date of Enter into Celiac Disease Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Celiac Disease Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Celiac Disease Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Celiac Disease Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Celiac Disease Drugs Revenue Market Share by Type (2024-2033)
Table 27. Global Celiac Disease Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Celiac Disease Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global Celiac Disease Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Celiac Disease Drugs Revenue Market Share by Application (2024-2033)
Table 31. North America Celiac Disease Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Celiac Disease Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Celiac Disease Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Celiac Disease Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Celiac Disease Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Celiac Disease Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Celiac Disease Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Celiac Disease Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Celiac Disease Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Celiac Disease Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Celiac Disease Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Celiac Disease Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Celiac Disease Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Celiac Disease Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Celiac Disease Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Celiac Disease Drugs Product
Table 49. Roche Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck Celiac Disease Drugs Product
Table 54. Merck Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Celiac Disease Drugs Product
Table 59. Johnson & Johnson Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. BiolineRx Company Detail
Table 62. BiolineRx Business Overview
Table 63. BiolineRx Celiac Disease Drugs Product
Table 64. BiolineRx Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 65. BiolineRx Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Celiac Disease Drugs Product
Table 69. Pfizer Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Innovate Biopharmaceuticals Company Detail
Table 72. Innovate Biopharmaceuticals Business Overview
Table 73. Innovate Biopharmaceuticals Celiac Disease Drugs Product
Table 74. Innovate Biopharmaceuticals Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 75. Innovate Biopharmaceuticals Recent Development
Table 76. ImmusanT Company Detail
Table 77. ImmusanT Business Overview
Table 78. ImmusanT Celiac Disease Drugs Product
Table 79. ImmusanT Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 80. ImmusanT Recent Development
Table 81. Novartis Company Detail
Table 82. Novartis Business Overview
Table 83. Novartis Celiac Disease Drugs Product
Table 84. Novartis Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Bristol-Myers Squibb Company Detail
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Celiac Disease Drugs Product
Table 89. Bristol-Myers Squibb Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Immunomedics Company Detail
Table 92. Immunomedics Business Overview
Table 93. Immunomedics Celiac Disease Drugs Product
Table 94. Immunomedics Revenue in Celiac Disease Drugs Business (2018-2023) & (US$ Million)
Table 95. Immunomedics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Celiac Disease Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Celiac Disease Drugs Market Share by Type: 2022 VS 2033
Figure 3. First Line of Treatment Features
Figure 4. Second Line of Treatment Features
Figure 5. Global Celiac Disease Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Celiac Disease Drugs Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Celiac Disease Drugs Report Years Considered
Figure 12. Global Celiac Disease Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Celiac Disease Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Celiac Disease Drugs Market Share by Region: 2022 VS 2033
Figure 15. Global Celiac Disease Drugs Market Share by Players in 2022
Figure 16. Global Top Celiac Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Celiac Disease Drugs Revenue in 2022
Figure 18. North America Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Celiac Disease Drugs Market Share by Country (2018-2033)
Figure 20. United States Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Celiac Disease Drugs Market Share by Country (2018-2033)
Figure 24. Germany Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Celiac Disease Drugs Market Share by Region (2018-2033)
Figure 32. China Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Celiac Disease Drugs Market Share by Country (2018-2033)
Figure 40. Mexico Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Celiac Disease Drugs Market Share by Country (2018-2033)
Figure 44. Turkey Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Celiac Disease Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 49. BiolineRx Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 51. Innovate Biopharmaceuticals Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 52. ImmusanT Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 55. Immunomedics Revenue Growth Rate in Celiac Disease Drugs Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed